{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:16:20Z","timestamp":1788347780905,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023R206"],"award-info":[{"award-number":["2023R206"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12677-y","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:47:13Z","timestamp":1788346033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bruceine D suppressed osteoclast formation via STAT3\/NF-\u03baB\/NFATc1 signaling and protected postmenopausal osteoporosis"],"prefix":"10.1007","volume":"53","author":[{"given":"Sisi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XinYi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"10169","key":"12677_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/s0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD (2019) Osteoporosis. Lancet. (London England) 393(10169):364\u2013376. https:\/\/doi.org\/10.1016\/s0140-6736(18)32112-3","journal-title":"(London England)"},{"issue":"7","key":"12677_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nrendo.2015.71","volume":"11","author":"IR Reid","year":"2015","unstructured":"Reid IR (2015) Short-term and long-term effects of osteoporosis therapies. Nat reviews Endocrinol 11(7):418\u2013428. https:\/\/doi.org\/10.1038\/nrendo.2015.71","journal-title":"Nat reviews Endocrinol"},{"issue":"21","key":"12677_CR3","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","volume":"389","author":"MD Walker","year":"2023","unstructured":"Walker MD, Shane E (2023) Postmenopausal Osteoporosis. N Engl J Med 389(21):1979\u20131991. https:\/\/doi.org\/10.1056\/NEJMcp2307353","journal-title":"N Engl J Med"},{"issue":"5","key":"12677_CR4","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"Eastell R, Rosen CJ, Black DM et al (2019) Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab 104(5):1595\u20131622. https:\/\/doi.org\/10.1210\/jc.2019-00221","journal-title":"J Clin Endocrinol Metab"},{"key":"12677_CR5","doi-asserted-by":"publisher","first-page":"1623990","DOI":"10.3389\/fphar.2025.1623990","volume":"16","author":"C Xin","year":"2025","unstructured":"Xin C, Zhang G, Shen Z et al (2025) Pharmacological mechanism of natural products to treat osteoporosis: a focus on the autophagy. Front Pharmacol 16:1623990. https:\/\/doi.org\/10.3389\/fphar.2025.1623990","journal-title":"Front Pharmacol"},{"issue":"3","key":"12677_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00198-017-4255-1","volume":"29","author":"Z Wang","year":"2018","unstructured":"Wang Z, Wang D, Yang D et al (2018) The effect of icariin on bone metabolism and its potential clinical application. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation. USA 29(3):535\u2013544. https:\/\/doi.org\/10.1007\/s00198-017-4255-1","journal-title":"USA"},{"key":"12677_CR7","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.2147\/dddt.S515930","volume":"19","author":"C Xiu","year":"2025","unstructured":"Xiu C, Luo H, Huang W et al (2025) Lobetyolin Suppressed Osteoclastogenesis and Alleviated Bone Loss in Ovariectomy-Induced Osteoporosis via Hindering p50\/p65 Nuclear Translocation and Downstream NFATc1\/c-Fos Expression. Drug Des Devel Ther 19:4689\u20134715. https:\/\/doi.org\/10.2147\/dddt.S515930","journal-title":"Drug Des Devel Ther"},{"key":"12677_CR8","doi-asserted-by":"publisher","first-page":"1249418","DOI":"10.3389\/fphar.2023.1249418","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang S, Sun Y, Kapilevich L et al (2023) Protective effects of curcumin against osteoporosis and its molecular mechanisms: a recent review in preclinical trials. Front Pharmacol 14:1249418. https:\/\/doi.org\/10.3389\/fphar.2023.1249418","journal-title":"Front Pharmacol"},{"issue":"14","key":"12677_CR9","doi-asserted-by":"publisher","first-page":"8254","DOI":"10.1021\/acs.jafc.4c06689","volume":"73","author":"S Li","year":"2025","unstructured":"Li S, Zhang Y, Ding S et al (2025) Curcumin Ameliorated Glucocorticoid-Induced Osteoporosis While Modulating the Gut Microbiota and Serum Metabolome. J Agric Food Chem 73(14):8254\u20138276. https:\/\/doi.org\/10.1021\/acs.jafc.4c06689","journal-title":"J Agric Food Chem"},{"key":"12677_CR10","doi-asserted-by":"publisher","first-page":"154928","DOI":"10.1016\/j.phymed.2023.154928","volume":"123","author":"H Chen","year":"2024","unstructured":"Chen H, Han X, Zhang Y et al (2024) Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-\u03b1 stimulation by inhibiting Notch1-Jagged1\/NF-\u03baB(p65) signaling. Phytomedicine: Int J phytotherapy phytopharmacology 123:154928. https:\/\/doi.org\/10.1016\/j.phymed.2023.154928","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"key":"12677_CR11","doi-asserted-by":"publisher","first-page":"157972","DOI":"10.1016\/j.phymed.2026.157972","volume":"153","author":"C Fu","year":"2026","unstructured":"Fu C, Huang R, Sun Q et al (2026) Bruceine D ameliorates cholestatic liver injury by selectively modulating bile acid synthesis and activating FXR-SHP signaling. Phytomedicine: Int J phytotherapy phytopharmacology 153:157972. https:\/\/doi.org\/10.1016\/j.phymed.2026.157972","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"issue":"4","key":"12677_CR12","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbrc.2020.03.097","volume":"526","author":"Y Yang","year":"2020","unstructured":"Yang Y, Kong F, Ding Q et al (2020) Bruceine D elevates Nrf2 activation to restrain Parkinson\u2019s disease in mice through suppressing oxidative stress and inflammatory response. Biochem Biophys Res Commun 526(4):1013\u20131020. https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.097","journal-title":"Biochem Biophys Res Commun"},{"key":"12677_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.biochi.2021.01.009","volume":"182","author":"CD Mohan","year":"2021","unstructured":"Mohan CD, Liew YY, Jung YY et al (2021) Brucein D modulates MAPK signaling cascade to exert multi-faceted anti-neoplastic actions against breast cancer cells. Biochimie 182:140\u2013151. https:\/\/doi.org\/10.1016\/j.biochi.2021.01.009","journal-title":"Biochimie"},{"issue":"17","key":"12677_CR14","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1002\/cam4.2612","volume":"8","author":"S Wang","year":"2019","unstructured":"Wang S, Hu H, Zhong B et al (2019) Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway. Cancer Med 8(17):7345\u20137358. https:\/\/doi.org\/10.1002\/cam4.2612","journal-title":"Cancer Med"},{"issue":"1","key":"12677_CR15","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1186\/s40001-025-03270-3","volume":"30","author":"P Chen","year":"2025","unstructured":"Chen P, Xu Q, Wu S et al (2025) Bruceine D inhibits hepatocellular carcinoma by regulating the STAT3 signaling pathway through HSP70. Eur J Med Res 30(1):1010. https:\/\/doi.org\/10.1186\/s40001-025-03270-3","journal-title":"Eur J Med Res"},{"issue":"3","key":"12677_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/sj.bjc.6605487","volume":"102","author":"ST Lau","year":"2010","unstructured":"Lau ST, Lin ZX, Leung PS (2010) Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappaB signalling pathways in human pancreatic adenocarcinoma cells. Br J Cancer 102(3):583\u2013593. https:\/\/doi.org\/10.1038\/sj.bjc.6605487","journal-title":"Br J Cancer"},{"key":"12677_CR17","doi-asserted-by":"publisher","first-page":"112382","DOI":"10.1016\/j.mce.2024.112382","volume":"594","author":"G Cai","year":"2024","unstructured":"Cai G, Song X, Luo H et al (2024) NLRP3 blockade by MCC950 suppressed osteoclastogenesis via NF-\u03baB\/c-Fos\/NFATc1 signal pathway and alleviated bone loss in diabetes mellitus. Mol Cell Endocrinol 594:112382. https:\/\/doi.org\/10.1016\/j.mce.2024.112382","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"12677_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/biom8040157","volume":"8","author":"BS Lee","year":"2018","unstructured":"Lee BS (2018) Myosins in Osteoclast Formation and Function. Biomolecules 8(4):157. https:\/\/doi.org\/10.3390\/biom8040157","journal-title":"Biomolecules"},{"issue":"3\u20134","key":"12677_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejcb.2005.09.008","volume":"85","author":"P Jurdic","year":"2006","unstructured":"Jurdic P, Saltel F, Chabadel A et al (2006) Podosome and sealing zone: specificity of the osteoclast model. Eur J Cell Biol 85(3\u20134):195\u2013202. https:\/\/doi.org\/10.1016\/j.ejcb.2005.09.008","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"12677_CR20","doi-asserted-by":"publisher","first-page":"2665867","DOI":"10.1080\/15384047.2026.2665867","volume":"27","author":"Y Zhu","year":"2026","unstructured":"Zhu Y, Xu X, Hong X et al (2026) Inhibition of STAT3-mediated glycolysis by bruceine D suppresses non-small-cell lung cancer progression in vitro and in vivo. Cancer Biol Ther 27(1):2665867. https:\/\/doi.org\/10.1080\/15384047.2026.2665867","journal-title":"Cancer Biol Ther"},{"key":"12677_CR21","doi-asserted-by":"publisher","first-page":"177994","DOI":"10.1016\/j.ejphar.2025.177994","volume":"1003","author":"J Ma","year":"2025","unstructured":"Ma J, Cao D, Zhang Y et al (2025) Bruceine D inhibits CAF-promoted angiogenesis of breast cancer via suppressing IL-6-mediated activation of the STAT3\/Notch1\/VEGFR2 axis. Eur J Pharmacol 1003:177994. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177994","journal-title":"Eur J Pharmacol"},{"key":"12677_CR22","doi-asserted-by":"publisher","first-page":"1370900","DOI":"10.3389\/fphar.2024.1370900","volume":"15","author":"G Cao","year":"2024","unstructured":"Cao G, Hu S, Ning Y et al (2024) Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity. Front Pharmacol 15:1370900. https:\/\/doi.org\/10.3389\/fphar.2024.1370900","journal-title":"Front Pharmacol"},{"issue":"8","key":"12677_CR23","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1142\/s0192415x23500866","volume":"51","author":"K Li","year":"2023","unstructured":"Li K, Jiang Y, Wang N et al (2023) Traditional Chinese Medicine in Osteoporosis Intervention and the Related Regulatory Mechanism of Gut Microbiome. Am J Chin Med 51(8):1957\u20131981. https:\/\/doi.org\/10.1142\/s0192415x23500866","journal-title":"Am J Chin Med"},{"key":"12677_CR24","doi-asserted-by":"publisher","unstructured":"Sin ZW, Bhardwaj V, Pandey AK et al (2020) A brief overview of antitumoral actions of bruceine D. Exploration of targeted anti-tumor therapy 1. 4200\u2013217. https:\/\/doi.org\/10.37349\/etat.2020.00013","DOI":"10.37349\/etat.2020.00013"},{"issue":"1","key":"12677_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12964-022-00924-1","volume":"20","author":"X Hou","year":"2022","unstructured":"Hou X, Tian F (2022) STAT3-mediated osteogenesis and osteoclastogenesis in osteoporosis. Cell communication signaling: CCS 20(1):112. https:\/\/doi.org\/10.1186\/s12964-022-00924-1","journal-title":"Cell communication signaling: CCS"},{"key":"12677_CR26","doi-asserted-by":"publisher","first-page":"1639430","DOI":"10.3389\/fcell.2025.1639430","volume":"13","author":"L Yin","year":"2025","unstructured":"Yin L, Sun C, Zhang J et al (2025) Critical signaling pathways in osteoclast differentiation and bone resorption: mechanisms and therapeutic implications for periprosthetic osteolysis. Front cell Dev biology 13:1639430. https:\/\/doi.org\/10.3389\/fcell.2025.1639430","journal-title":"Front cell Dev biology"},{"issue":"1","key":"12677_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41421-025-00853-6","volume":"12","author":"S Zhu","year":"2026","unstructured":"Zhu S, Yan MQ, Masson A et al (2026) Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases. Cell discovery 12(1):6. https:\/\/doi.org\/10.1038\/s41421-025-00853-6","journal-title":"Cell discovery"},{"issue":"1","key":"12677_CR28","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1038\/s41598-024-53235-5","volume":"14","author":"T Phan Van","year":"2024","unstructured":"Phan Van T, Huyen Ton Nu Bao T, Leya M et al (2024) Amlexanox attenuates LPS-induced neuroinflammatory responses in microglial cells via inhibition of NF-\u03baB and STAT3 signaling pathways. Sci Rep 14(1):2744. https:\/\/doi.org\/10.1038\/s41598-024-53235-5","journal-title":"Sci Rep"},{"issue":"1","key":"12677_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He G, Karin M (2011) NF-\u03baB and STAT3 - key players in liver inflammation and cancer. Cell Res 21(1):159\u2013168. https:\/\/doi.org\/10.1038\/cr.2010.183","journal-title":"Cell Res"},{"key":"12677_CR30","doi-asserted-by":"publisher","first-page":"116451","DOI":"10.1016\/j.biopha.2024.116451","volume":"174","author":"Y Xu","year":"2024","unstructured":"Xu Y, Chen Z, Lu X et al (2024) Targeted inhibition of STAT3 (Tyr705) by xanthatin alleviates osteoarthritis progression through the NF-\u03baB signaling pathway. Biomed pharmacotherapy = Biomedecine pharmacotherapie 174:116451. https:\/\/doi.org\/10.1016\/j.biopha.2024.116451","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"issue":"7","key":"12677_CR31","doi-asserted-by":"publisher","first-page":"e0159891","DOI":"10.1371\/journal.pone.0159891","volume":"11","author":"YH Joung","year":"2016","unstructured":"Joung YH, Darvin P, Kang DY et al (2016) Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-\u03baB and STAT3 Activities. PLoS ONE 11(7):e0159891. https:\/\/doi.org\/10.1371\/journal.pone.0159891","journal-title":"PLoS ONE"},{"issue":"1","key":"12677_CR32","doi-asserted-by":"publisher","first-page":"20292","DOI":"10.1038\/s41598-024-71259-9","volume":"14","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Li B, Wu S et al (2024) Bergenin protects against osteoarthritis by inhibiting STAT3, NF-\u03baB and Jun pathways and suppressing osteoclastogenesis. Sci Rep 14(1):20292. https:\/\/doi.org\/10.1038\/s41598-024-71259-9","journal-title":"Sci Rep"},{"key":"12677_CR33","doi-asserted-by":"publisher","unstructured":"Yang J, Tang R, Yi J et al (2019) Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis via NF-\u03baB-NFATc1 signal pathway. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 33(6):7261\u20137273. https:\/\/doi.org\/10.1096\/fj.201802172R","DOI":"10.1096\/fj.201802172R"},{"issue":"4","key":"12677_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bbrc.2013.04.084","volume":"435","author":"CH Li","year":"2013","unstructured":"Li CH, Zhao JX, Sun L et al (2013) AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis. Biochem Biophys Res Commun 435(4):533\u2013539. https:\/\/doi.org\/10.1016\/j.bbrc.2013.04.084","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"12677_CR35","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.4049\/jimmunol.178.9.5588","volume":"178","author":"K Kim","year":"2007","unstructured":"Kim K, Lee J, Kim JH et al (2007) Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor. J Immunol (Baltimore Md: 1950) 178(9):5588\u20135594. https:\/\/doi.org\/10.4049\/jimmunol.178.9.5588","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"4","key":"12677_CR36","doi-asserted-by":"publisher","first-page":"e70152","DOI":"10.1002\/mco2.70152","volume":"6","author":"MA Samad","year":"2025","unstructured":"Samad MA, Ahmad I, Hasan A et al (2025) STAT3 Signaling Pathway in Health and Disease. MedComm 6(4):e70152. https:\/\/doi.org\/10.1002\/mco2.70152","journal-title":"MedComm"},{"issue":"1","key":"12677_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00441-010-1044-y","volume":"343","author":"LJ Quinton","year":"2011","unstructured":"Quinton LJ, Mizgerd JP (2011) NF-\u03baB and STAT3 signaling hubs for lung innate immunity. Cell Tissue Res 343(1):153\u2013165. https:\/\/doi.org\/10.1007\/s00441-010-1044-y","journal-title":"Cell Tissue Res"},{"issue":"11","key":"12677_CR38","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1586\/14737175.2014.964211","volume":"14","author":"GK Gray","year":"2014","unstructured":"Gray GK, McFarland BC, Nozell SE et al (2014) NF-\u03baB and STAT3 in glioblastoma: therapeutic targets coming of age. Expert Rev Neurother 14(11):1293\u20131306. https:\/\/doi.org\/10.1586\/14737175.2014.964211","journal-title":"Expert Rev Neurother"},{"issue":"12","key":"12677_CR39","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/embor.2009.243","volume":"10","author":"J Bollrath","year":"2009","unstructured":"Bollrath J, Greten FR (2009) IKK\/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 10(12):1314\u20131319. https:\/\/doi.org\/10.1038\/embor.2009.243","journal-title":"EMBO Rep"},{"issue":"4","key":"12677_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1586\/ern.10.21","volume":"10","author":"GP Atkinson","year":"2010","unstructured":"Atkinson GP, Nozell SE, Benveniste ET (2010) NF-kappaB and STAT3 signaling in glioma: targets for future therapies. Expert Rev Neurother 10(4):575\u2013586. https:\/\/doi.org\/10.1586\/ern.10.21","journal-title":"Expert Rev Neurother"},{"key":"12677_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2025.07.009","author":"RD Han","year":"2025","unstructured":"Han RD, Tian N, Sun ZG et al (2025) Vitamin C Protects Against Myocardial Damage Induced by Sepsis by Regulating the JAK2\/STAT3 and NF-\u03baB Signaling Pathways. J Surg Res. https:\/\/doi.org\/10.1016\/j.jss.2025.07.009. 314:209\u2009\u2013\u200919","journal-title":"J Surg Res"},{"issue":"3","key":"12677_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s13238-013-2084-3","volume":"4","author":"Y Fan","year":"2013","unstructured":"Fan Y, Mao R, Yang J (2013) NF-\u03baB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell 4(3):176\u2013185. https:\/\/doi.org\/10.1007\/s13238-013-2084-3","journal-title":"Protein Cell"},{"issue":"10","key":"12677_CR43","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1182\/blood.2020009404","volume":"138","author":"A Schmitt","year":"2021","unstructured":"Schmitt A, Xu W, Bucher P et al (2021) Dimethyl fumarate induces ferroptosis and impairs NF-\u03baB\/STAT3 signaling in DLBCL. Blood 138(10):871\u2013884. https:\/\/doi.org\/10.1182\/blood.2020009404","journal-title":"Blood"},{"issue":"1","key":"12677_CR44","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12974-017-1009-0","volume":"14","author":"JH Park","year":"2017","unstructured":"Park JH, Seo YH, Jang JH et al (2017) Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB\/STAT3\/ERK and mitochondria-mediated apoptosis pathway. J Neuroinflamm 14(1):240. https:\/\/doi.org\/10.1186\/s12974-017-1009-0","journal-title":"J Neuroinflamm"},{"key":"12677_CR45","doi-asserted-by":"publisher","unstructured":"Yang S, Zhang X, Liao X et al (2024) Icariin regulates RANKL-induced osteoclast differentiation via the ER\u03b1\/c-Src\/RANK signaling. Biomedical Mater (Bristol England) 19(2). https:\/\/doi.org\/10.1088\/1748-605X\/ad2554","DOI":"10.1088\/1748-605X\/ad2554"},{"key":"12677_CR46","doi-asserted-by":"publisher","first-page":"600156","DOI":"10.3389\/fphar.2020.600156","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Niu C, Jiang Z et al (2020) Targeted Delivery of Curcumin to Polyethylene-Induced Osteolysis by Magnetically Guided Zoledronate-Anchored Poly Lactic-Co-Glycolic Acid Nanoparticles via Repressing NF-\u03baB Signaling. Front Pharmacol 11:600156. https:\/\/doi.org\/10.3389\/fphar.2020.600156","journal-title":"Front Pharmacol"},{"key":"12677_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jchromb.2017.08.037","volume":"1063","author":"F Man","year":"2017","unstructured":"Man F, Choo CY (2017) HPLC-MS\/MS method for bioavailability study of bruceines D & E in rat plasma. J Chromatogr B Anal Technol biomedical life Sci 1063:183\u2013188. https:\/\/doi.org\/10.1016\/j.jchromb.2017.08.037","journal-title":"J Chromatogr B Anal Technol biomedical life Sci"},{"key":"12677_CR48","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3389\/fphar.2017.00936","volume":"8","author":"ZQ Lai","year":"2017","unstructured":"Lai ZQ, Ip SP, Liao HJ et al (2017) Brucein D, a Naturally Occurring Tetracyclic Triterpene Quassinoid, Induces Apoptosis in Pancreatic Cancer through ROS-Associated PI3K\/Akt Signaling Pathway. Front Pharmacol 8:936. https:\/\/doi.org\/10.3389\/fphar.2017.00936","journal-title":"Front Pharmacol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12677-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12677-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12677-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:47:14Z","timestamp":1788346034000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12677-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12677"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12677-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"26 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1508"}}